137 related articles for article (PubMed ID: 28369262)
1. Submandibular Sialoadenitis in an Infant Exposed to Adalimumab and Infliximab in Utero.
Vestergaard T; Brock B; Christensen LA; Julsgaard M
J Crohns Colitis; 2017 Oct; 11(10):1284-1285. PubMed ID: 28369262
[No Abstract] [Full Text] [Related]
2. Small-Fiber Neuropathy in a Pediatric Patient Following Anti-Tumor Necrosis Factor-α Therapy for Ulcerative Colitis.
Breton J; Ellazam B; Haddad E; Deslandres C
J Pediatr Gastroenterol Nutr; 2018 Jun; 66(6):e159-e161. PubMed ID: 29620599
[No Abstract] [Full Text] [Related]
3. Prospective comparison of preference and efficacy of adalimumab and infliximab for treating ulcerative colitis naive to antitumor necrosis factor therapy.
Mizoshita T; Katano T; Tanida S; Hirano A; Miyaki T; Ozeki K; Suzuki Y; Sugimura N; Kataoka H; Joh T
Medicine (Baltimore); 2017 Aug; 96(32):e7800. PubMed ID: 28796080
[TBL] [Abstract][Full Text] [Related]
4. Real-life outcome of anti-tumor necrosis factor α in the ambulatory treatment of ulcerative colitis.
Baki E; Zwickel P; Zawierucha A; Ehehalt R; Gotthardt D; Stremmel W; Gauss A
World J Gastroenterol; 2015 Mar; 21(11):3282-90. PubMed ID: 25805935
[TBL] [
